Seventh Framework Programme and European Commission logos

Advancing the development of life-saving drugs for cardiovascular diseases

Leiden University Medical Center

The Netherlands

Leiden University Medical Center (LUMC) will chair and coordinate the human validation studies, and integrate the knowledge development within WP3 (Target validation – clinical tissue). LUMC will provide the clinical and pathological expertise required in WP3 (Target validation – clinical tissue). LUMC will coordinate the workflow required and validate candidate targets in relevant clinical material using tissue biobank validation workflow, and expand and extent the biobank activities in order to address unmet needs.

Leiden University has six faculties, over 50 departments and enjoys an outstanding international reputation. In 2012 Leiden was the highest ranked university in the Netherlands in the Times Higher Education World University Rankings, where it was rated as the 64th best university worldwide. Shanghai Jiao Tong University’s 2011 Academic Ranking of World Universities ranked Leiden University as the 65th best university worldwide. Research within the department of vascular surgery is embedded in the Eindhoven Laboratory for Vascular and Regenerative medicine. The group consists of about 14 researchers and is mainly dedicated to the role of inflammation in vascular disease. The group is well recognized for its experimental translational work in the field of vascular diseases.